Drs Burger and Woods join current SAB members Shelly Heimfeld, Ph.D., Director of the Cellular Therapy Laboratory at the Fred Hutchinson Cancer Research Center; Dayong Gao, Ph.D., Professor of Mechanical and Biomedical Engineering at the University of Washington; Darin Weber, Ph.D., Senior Consultant, Cell and Gene Therapies at Biologics Consulting Group; Andrew Hinson, Vice President of Clinical and Regulatory Affairs at Symphony Medical; and Lizabeth Cardwell, Principal of Compliance Consulting.
About BioLife Solutions
BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells, tissues, and organs. The Company's proprietary HypoThermosol(R) and CryoStor(TM) platform of solutions are marketed to academic and commercial organizations involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce or prevent preservation-induced, delayed-onset cell damage and death. BioLife's enabling technology provides academic and clinical researchers significant improvements in post-thaw cell, tissue, and organ viability and function. For more information please visit http://www.biolifesolutions.com.
This news release contains forward-looking statements as that term is
defined in the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include any statements that relate to the
intent, belief, plans or expectations of the Company or its management, or
that are not a statement of historical fact. Any forward-looking statements
in this news release are based on current expectations and beliefs and are
subject to numerous risks and uncertainties that could cause actual
|SOURCE BioLife Solutions, Inc.|
Copyright©2007 PR Newswire.
All rights reserved